LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features
LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features
复制标题
LUADpp:基于体细胞突变特征的肺腺癌预后的有效预测模型
DOI:
10.1186/s12885-019-5433-7
复制
发表时间:
2019-03
期刊:
影响因子:
3.8
通讯作者:
Wang Yejun
中科院分区:
文献类型:
--
作者:
Yu Jiaxian;Hu Yueming;Xu Yafei;Wang Jue;Kuang Jiajie;Zhang Wei;Shao Jianlin;Guo Dianjing;Wang Yejun
BackgroundLung adenocarcinoma is the most common type of lung cancers. Whole-genome sequencing studies disclosed the genomic landscape of lung adenocarcinomas. however, it remains unclear if the genetic alternations could guide prognosis prediction. Effective genetic markers and their based prediction models are also at a lack for prognosis evaluation.MethodsWe obtained the somatic mutation data and clinical data for 371 lung adenocarcinoma cases from The Cancer Genome Atlas. The cases were classified into two prognostic groups (3-year survival), and a comparison was performed between the groups for the somatic mutation frequencies of genes, followed by development of computational models to discrete the different prognosis.ResultsGenes were found with higher mutation rates in good (≥ 3-year survival) than in poor (< 3-year survival) prognosis group of lung adenocarcinoma patients. Genes participating in cell-cell adhesion and motility were significantly enriched in the top gene list with mutation rate difference between the good and poor prognosis group. Support Vector Machine models with the gene somatic mutation features could well predict prognosis, and the performance improved as feature size increased. An 85-gene model reached an average cross-validated accuracy of 81% and anAreaUnder theCurve (AUC) of 0.896 for theReceiverOperatingCharacteristic (ROC) curves. The model also exhibited good inter-stage prognosis prediction performance, with an average AUC of 0.846 for the ROC curves.ConclusionThe prognosis of lung adenocarcinomas is related with somatic gene mutations. The genetic markers could be used for prognosis prediction and furthermore provide guidance for personal medicine.
登录
查看更多内容
影响因子:
3.7
作者:
Wan YW;Sabbagh E;Raese R;Qian Y;Luo D;Denvir J;Vallyathan V;Castranova V;Guo NL
通讯作者:
Guo NL
影响因子:
120.1
作者:
Daniel Jones
通讯作者:
Daniel Jones
DOI:
10.1891/9780826121646.0002
发表时间:
2018-09
期刊:
Cancer Rehabilitation
影响因子:
--
作者:
K. Miller;R. Siegel;R. Khan;A. Jemal
通讯作者:
K. Miller;R. Siegel;R. Khan;A. Jemal
影响因子:
82.9
作者:
Kohno T;Ichikawa H;Totoki Y;Yasuda K;Hiramoto M;Nammo T;Sakamoto H;Tsuta K;Furuta K;Shimada Y;Iwakawa R;Ogiwara H;Oike T;Enari M;Schetter AJ;Okayama H;Haugen A;Skaug V;Chiku S;Yamanaka I;Arai Y;Watanabe S;Sekine I;Ogawa S;Harris CC;Tsuda H;Yoshida T;Yokota J;Shibata T
通讯作者:
Shibata T
影响因子:
28.2
作者:
Drilon A;Wang L;Hasanovic A;Suehara Y;Lipson D;Stephens P;Ross J;Miller V;Ginsberg M;Zakowski MF;Kris MG;Ladanyi M;Rizvi N
通讯作者:
Rizvi N